R J Biotech Limited reported earnings results for the full year ended March 31, 2022. For the full year, the company reported sales was INR 138.97 million compared to INR 157.96 million a year ago. Revenue was INR 145.71 million compared to INR 157.96 million a year ago.

Net loss was INR 91.58 million compared to INR 156.82 million a year ago. Basic loss per share from continuing operations was INR 9.67 compared to INR 16.56 a year ago.